Pre-Clinical Applications - MolecuLight US

Research Category:Species Detected/Biofilm, Pre-Clinical Applications

Detection of bacterial fluorescence from in vivo wound biofilms using a point‐of‐care fluorescence imaging device

International Wound Journal, 09 Feb 2021

Download Publication

Research Category:Species Detected/Biofilm, Pre-Clinical Applications

In vitro detection of porphyrin-producing wound bacteria with real-time fluorescence imaging

FUTURE MICROBIOLOGY, 26 Feb 2020

Download Publication

Research Category:Pre-Clinical Applications, Detection of Bacterial Burden

Autofluorescence imaging device for real-time detection and tracking of pathogenic bacteria in a mouse skin wound model: preclinical feasibility studies

Journal of Biomedical Optics, 2014, 19(8). doi: 10.1117/1.JBO.19.8.085002.

Download Publication

Ready to see the difference?

MolecuLight Headquarters

425 University Avenue Suite 700 Toronto, ON M5G 1T6 Canada

US Address MolecuLight Corp. 2403 Sidney Street, Suite 286 Pittsburgh, PA 15203

T. 1-877-818-4360
North American Toll Free:
1-877-818-4360
F.+1 647-362-4730
E: info@moleculight.com

MolecuLight is SOC ll^®
Type l Accredited:

MolecuLight awarded
Premier’s Technology
Breakthrough Designation

MolecuLight i:X
is designated as a:

MolecuLight included
in ISWCAP Consensus
Guidelines:

MolecuLight is a proud
corporate member of:

Global

USA

©2024
The MolecuLight® i:X and MolecuLightDX™ Imaging Devices are approved by Health Canada for sale in Canada and has CE marking for sale in the European Union.
The MolecuLight™ i:X and DX Imaging Devices have received FDA clearance.